TY - JOUR AU - Fatema Bassam Ahmed AU - Aili Lyu PY - 2021/10/26 Y2 - 2024/03/29 TI - A Review of Candidate Therapies for Beta Coronavirus a Molecular Research JF - Asian Pacific Journal of Cancer Care JA - apjcc VL - 6 IS - S1 SE - Review and Meta-analysis DO - 10.31557/apjcc.2021.6.S1.83-86 UR - http://waocp.com/journal/index.php/apjcc/article/view/700 AB - Coronavirus disease 2019 (COVID-19) is an infectious illness caused by the coronavirus 2 that causes severe acute respiratory illness (SARS-CoV-2). The first instance of this virus was reported on November 17th, 2019 in Wuhan, China. The COVID-19 outbreak is evidenced with devastating consequences such as 34.9% rate of mortality in 27 countries. The metastasizing of COVID-19 all over the world is alarmed to cause significant losses of human life, and for this there is no specific vaccination or therapy for COVID-19 in particular. The therapies suggested at this time are adapted from the treatments of Severe Acute Respiratory Syndrome (SARV-CoV). For instance, the development for a particular therapy or vaccination for COVID-19 is an urgent requirement. The pattern of study is based on investigating the research papers for the period of 2012-2020, identifying all the potential aspects of medical research contributing for the development of treatment against diverse families of coronavirus. By analyzing this approach, this study is aimed to provide a directed approach for developing appropriate therapy for COVID-19. ER -